PHYSIO-COVID: Implementation of Physiotherapy on COVID-19 Patients in ICU

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04347070
Collaborator
Société espagnole de pneumologie (SEPAR) (Other), Societe française de kinésithérapie en réanimation (SKR) (Other)
150
1
68
2.2

Study Details

Study Description

Brief Summary

Despite new charachersitics of COVID-19 patients, critical care implementation seems to be similar to those with Acute Respiratory Distress Syndrome (ARDS) in intensive care units (ICU).

Regarding the initial gravity of these patients, sedation and neuromuscular blockers are usually administrated, increasing the risk to develope an ICU-acquired weakness which is directly correlated to morbi-mortality and a burden during recovery.

Respiratory symptoms are mostly related to dyspnoea and non-productive cough, with only 33% of COVID-19 patient having a bronchial hypersecretion ; consequently, chest physiotherapy is only implemented in after case-by-case evaluation.

This unprecedented situation requires to identify how physiotherapy is being implemented in COVID-19 patients in ICU.

This retrospective, multicentric study aims to identify the charactheristics of physiotherapy (type and time spent) implemented in Argentina, Belgium, Chili, France, Italy and Spain

Condition or Disease Intervention/Treatment Phase
  • Other: Phsyiotherapy

Detailed Description

  • Demographics data : hospitalisation date, ICU date, COVID+ date, extubation date, discharge date, mortality

  • ICU data : ventilatory mode, type of physiotherapy implemented (early rehabilitation, chest physiotherapy, time spent (minutes), number of interventions per day.

Study Design

Study Type:
Observational
Actual Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Implementation of Physiotherapy on COVID-19 Patients in Intensive Care Units : a Retrospective, Multicentric, International Study
Actual Study Start Date :
Apr 1, 2017
Actual Primary Completion Date :
Sep 1, 2020
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Patients accepted in ICU diagnosed with COVID-19

Patients accepted in ICU diagnosed with COVID-19

Other: Phsyiotherapy
To observe if patients with COVID-19 benefice of physiothersapy, which kind and how many time

Outcome Measures

Primary Outcome Measures

  1. Time of physiotherapy [1 day]

    Time of physiotherapy (minutes)

  2. Time of physiotherapy [3 day]

    Time of physiotherapy (minutes)

  3. Time of physiotherapy [7 day]

    Time of physiotherapy (minutes)

Secondary Outcome Measures

  1. Type of physiotherapy implemented [1 day]

    Type of physiotherapy , early rehabilitation or chest phsyitoherapy

  2. Type of physiotherapy implemented [3 day]

    Type of physiotherapy , early rehabilitation or chest phsyitoherapy

  3. Type of physiotherapy implemented [7 day]

    Type of physiotherapy , early rehabilitation or chest phsyitoherapy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Age > 18 years

  • Patient admitted in ICU

  • Patient with COVID-19 diagnosis

Exclusion criteria:
  • Explicite denie to participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Uhmontpellier Montpellier France 34295

Sponsors and Collaborators

  • University Hospital, Montpellier
  • Société espagnole de pneumologie (SEPAR)
  • Societe française de kinésithérapie en réanimation (SKR)

Investigators

  • Study Director: Roberto Martinez-Alejos, MD, PhD, University Hospital, Montpellier

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT04347070
Other Study ID Numbers:
  • RECHMPL20_0175
First Posted:
Apr 15, 2020
Last Update Posted:
Dec 29, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Montpellier
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 29, 2020